International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors

Youngstein T., Hoffmann P., Gül A., Lane T., Williams R., Rowczenio D. M. , ...More

RHEUMATOLOGY, vol.56, no.12, pp.2102-2108, 2017 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 56 Issue: 12
  • Publication Date: 2017
  • Doi Number: 10.1093/rheumatology/kex305
  • Journal Name: RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.2102-2108
  • Keywords: interleukin-1 inhibitors, anakinra, canakinumab, pregnancy, autoinflammatory disease, CAPS, TRAPS, biologic therapies, familial Mediterranean fever, adult onset stills disease, FAMILIAL MEDITERRANEAN FEVER, AUTOINFLAMMATORY DISEASES, REPRODUCTIVE-SYSTEM, ANAKINRA, EMBRYO


Objective. To provide outcome data concerning pregnancies exposed to the Interleukin-1 (IL-1) inhibitors prior to conception in both men and women, during pregnancy and breast feeding.